$LGND Recent News A portfolio rotation for a

New Post Public Reply Private Reply Replies (0) Message Board

Dec 3, 2013 at 4:43 PM

$LGND Recent News

A portfolio rotation for a medium-term speculator
11:41 a.m. Oct. 29, 2013
- The Trading Deck

Leading growth titles stand tall
12:30 p.m. Oct. 17, 2013
- The Trading Deck

Forest Oil shares surge on Texas asset sale
4:48 p.m. Oct. 3, 2013
- Wallace Witkowski

Pfizer, Ligand menopause drug gets FDA approval
4:19 p.m. Oct. 3, 2013
- MarketWatch.com

Stock leaders stand strong, despite drift
12:13 p.m. Sept. 26, 2013
- The Trading Deck

A bull market not ready to be put to rest
11:14 a.m. Sept. 5, 2013
- The Trading Deck

Trade what you see, not what you believe
12:30 p.m. Aug. 29, 2013
- The Trading Deck

Ligand lifts '13 outlook; signs a license deal
6:44 a.m. March 14, 2013
- MarketWatch.com

Ligand, Glaxo win expanded approval for Promacta
10:13 a.m. Nov. 19, 2012
- MarketWatch.com

12 biotech stocks hit 52-week highs
2:43 p.m. July 27, 2012
- Val Brickates Kennedy

Seagate, US Airways among top picks of Sabrient's Brown

9:34 a.m. May 4, 2012
- blogs.marketwatch.com

Pfizer to seek OK for long-stalled menopause drug
1:17 p.m. Jan. 30, 2012
- MarketWatch.com

How corporate insiders reacted to Japan
11:01 p.m. March 22, 2011
- Mark Hulbert

Somaxon paces decliners in drug sector
11:12 a.m. Nov. 19, 2010
- Val Brickates Kennedy

Insider Trading Alert - NVR, AN, PPS, BRCM And LGND Traded By Insiders

10:15 a.m. Dec. 2, 2013
- TheStreet.com

Goldman reiterates bullish rating on Amgen, sees Kyprolis sales ahead of consensus

11:27 a.m. Nov. 29, 2013
- Seeking Alpha

Ligand Pharmaceuticals (LGND) Jumps: Stock Rises 5.5% - Tale of the Tape

8:44 a.m. Nov. 27, 2013
- Zacks.com

Ligand rebounds as Summer Street strikes upbeat tone on Kyprolis

9:50 a.m. Nov. 22, 2013
- Seeking Alpha

BofA note spooks Amgen, Ligand investors

3:20 p.m. Nov. 21, 2013
- Seeking Alpha

A Few Stocks Form Bases, But Have Flaws

5:30 p.m. Nov. 20, 2013
- Investors Business Daily

Ligand Pharmaceuticals On Pace For Annual Profit

4:25 p.m. Nov. 5, 2013
- Investors Business Daily

Ligand Pharmaceuticals Incorporated Management Discusses Q3 2013 Results - Earnings Call Transcript

3:20 p.m. Oct. 30, 2013
- Seeking Alpha

Short Interest Makes 14.4% Move For LGND

3:40 p.m. Oct. 25, 2013
- TheStreet.com

Ligand, NIC: Thinly Traded Stocks That Hold Promise

4:17 p.m. Oct. 24, 2013
- Investors Business Daily

Pfizer: The Menopause Opportunity

5:45 p.m. Oct. 18, 2013
- Seeking Alpha

Hedge Funds Are Buying 8 Rallying Healthcare Stocks Benefitting From Obamacare

5:05 p.m. Oct. 15, 2013
- TheStreet.com

Put A Royalty Legend In Your Portfolio With Ligand Pharmaceuticals

8:25 a.m. Oct. 15, 2013
- Seeking Alpha

Amgen: GSK's Promacta Stealing Nplate's Thunder

11:47 a.m. Oct. 11, 2013
- Seeking Alpha

Pfizer: Pregnant Horses And Menopausal Women Bring In A Small Fortune

5:13 p.m. Oct. 9, 2013
- Seeking Alpha

IND for Ligand's LGD-6972 Accepted - Analyst Blog

6:07 p.m. Oct. 8, 2013
- Zacks.com

Did Pfizer and Ligand Just Get a New Winning Drug Approved?

4:07 p.m. Oct. 7, 2013
- Wall St. Cheat Sheet

FDA Approves New Hot Flash Treatment for Menopause

4:33 a.m. Oct. 4, 2013
- InvestorPlace.com

Five FDA Approvals and Reviews at Risk Under a Government Shutdown
9:49 a.m. Sept. 30, 2013
- 247WallSt.com

First Week Of May 2014 Options Trading For Ligand Pharmaceuticals (LGND)

12:04 p.m. Sept. 27, 2013
- TheStreet.com

FDA Approvals, Scheduled Presentations, and Stock Price Movements - Research Report on Amgen, St. Jude Medical, Life Technologies, Ligand, and Infinity Pharmaceuticals
8:00 a.m. Nov. 29, 2013
- PR Newswire

Ligand Pharmaceuticals Set to Join the S&P SmallCap 600
5:37 p.m. Nov. 25, 2013
- PR Newswire

Financial Results, Agreements, Meetings, and Clinical Trials - Research Report on Cell Therapeutics, Akorn, Ligand, Intercept Pharmaceuticals and Ariad Pharmaceuticals
8:00 a.m. Nov. 20, 2013
- PR Newswire

Ligand Announces Highlights from Today's Analyst Day Event
4:05 p.m. Nov. 14, 2013
- BusinessWire

Ligand Initiates Phase 1 Trial with Glucagon Receptor Antagonist for Type 2 Diabetes
8:00 a.m. Nov. 12, 2013
- BusinessWire

Upcoming Conferences, Financial Results, Dividends, and Public Offerings - Research Report on Medicines Company, Isis, Ligand, Teleflex, and Tetraphase
8:00 a.m. Nov. 12, 2013
- PR Newswire

Reminder: Ligand to Host Analyst Day on November 14th in Chicago
8:00 a.m. Nov. 7, 2013
- BusinessWire

Healthcare Sector Announced Financial Results - Research Report on Ligand, Auxilium, STERIS, USANA, and Cardiovascular Systems
8:00 a.m. Nov. 4, 2013
- PR Newswire

New Appointments, Upcoming Earnings Releases, Regulatory Approvals, Status Updates and Informative Resources for New Treatment Options - Research Report on Mylan, Alkermes, Salix, Ligand and Hospira
8:31 a.m. Oct. 30, 2013
- PR Newswire

Ligand Reports Third Quarter Financial Results
7:30 a.m. Oct. 30, 2013
- BusinessWire

Ligand to Host Analyst Day on November 14th in Chicago
3:00 p.m. Oct. 14, 2013
- BusinessWire

Ligand to Report Third Quarter Results on October 30th
3:00 p.m. Oct. 9, 2013
- BusinessWire

Ligand Announces FDA Acceptance of Investigational New Drug Application for Glucagon Receptor Antagonist Program
7:00 a.m. Oct. 7, 2013
- BusinessWire

Ligand Partner Pfizer Receives FDA Approval for DUAVEE(TM) for the Treatment of Moderate-to-Severe Vasomotor Symptoms (Hot Flashes) Associated with Menopause and the Prevention of Postmenopausal Osteoporosis
4:00 p.m. Oct. 3, 2013
- BusinessWire

Regulatory Approval, New Appointments, Stock Price Movements, and Other Announcements - Research Report on Pfizer, Warner Chilcott, Rockwell Medical, InterMune, and Ligand
7:00 a.m. Oct. 2, 2013
- PR Newswire

Ligand Partner GSK Receives Marketing Authorization from the European Commission for Additional Revolade(TM) (Eltrombopag) Indication as the First Approved Treatment for Chronic Hepatitis C-Associated Thrombocytopenia
6:00 a.m. Sept. 24, 2013
- BusinessWire

Ligand Enters Global License Agreement with CURx Pharmaceuticals, Inc. for Captisol-Enabled(TM) Topiramate Injection
7:00 a.m. Aug. 14, 2013
- BusinessWire

RDInvesting Provides Investors with Free In-Depth Equity Reports on HALO, LGND, PCRX and SQI
7:51 a.m. Aug. 5, 2013
- ACCESSWIRE

Ligand Reports Second Quarter Financial Results
7:30 a.m. Aug. 1, 2013
- BusinessWire

New License Agreements and Financial Results Release - Research Report on Elan, Waters, InterMune, Spectranetics, and Ligand
7:00 a.m. July 29, 2013
- PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

$Aluminum Refractory Market to Hit $2.73B by 2031$

Riding the Aluminum Refractory Wave to 2031 Look, when you want to throw some cash in a market that's gaining steam, aluminum refractory materials might not be your first pick. But here's the thing: it's charging ahead to a cool $2.73 billion by 2031. And if you're keeping tabs on the likes of RHI Magnesita and Calderys, this is a sector that deserves a once-over. What...

CIMAMotor 2026: A Massive Gathering in Motorcycle Mecca

Unprecedented Scale at CIMAMotor 2026 Come September, the 24th China International Motorcycle Trade Exhibition, also known as CIMAMotor 2026, is set to roar through the corridors of the Chongqing International Expo Center. With more than 1,000 exhibitors and over 3,000 vehicles on display, it’s clear this isn’t just another trade show—this is a full-blown spectacle...

Huayan Robotics Hits IMTS 2026 with Cutting-Edge Tech

Unveiling Robotics Prowess at IMTS 2026 Every two years, the world of manufacturing gathers at the International Manufacturing Technology Show (IMTS), and this time, the spotlight is on Huayan Robotics. With the event drawing over 90,000 professionals, everybody with a finger on the pulse of intelligent manufacturing will be keen to see what Huayan has up its sleeve. This...

TECNO CAMON Slim 5G: Where Art Meets Tech

Unveiling the TECNO CAMON Slim 5G Okay, so imagine a tech brand saying, 'Why not make a phone that’s as much an art piece as it is a gadget?' TECNO just pulled this off with their latest CAMON Slim 5G. The thing's a sleek marvel measuring in at just 6.39mm. Seems like they took a fat-free diet approach to phone design, and not on the digital calories either. A Slim Body...

Lida Group Expands Global Modular Construction Services

Modular Construction's Expanding Footprint Behold Lida Group—a titan in the world of modular construction—taking ambitious strides into the global arena, reaching from the sand dunes of Saudi Arabia to the bustling corridors of the United Nations. If you haven't been paying attention, now's the time to get your head in the game. Their expansion isn't just about...

Automotive ECU Market Aims $160B by 2033

Automotive ECUs Under the Spotlight Picture this: By 2033, the automotive ECU market is expected to balloon to a whopping $160.59 billion. That's some serious cash, and it ain't just pocket change. This $47 billion jump from 2026 isn't just happening by accident—it's got everything to do with high-octane changes in the industry. With a 5.1% CAGR, you best believe it's a...

AI and Workforce Transformation: Zellis Connect 2026

AI Transformation: Hard Reality or Strategic Opportunity? The future of work. That’s what everyone’s buzzing about lately, isn’t it? AI poised to shake every nook and cranny. You're either riding the wave or getting crushed by it. It’s no longer some distant prospect—the challenge is right here, now. Come September 23, Zellis Connect 2026 is plunging headfirst...

Park Systems Expands in the Pacific Northwest

Strategic Move into Hillsboro Sparks Industry Buzz Park Systems, already a heavyweight in the nanometrology arena, just made a bold play with the opening of its latest regional office. Nestled in the tech-centric town of Hillsboro, Oregon, this hub is set to redefine how they handle technical support and customer management across the Pacific Northwest. It's like they're...

WEPSEA 2026 Propels Southeast Asia's Packaging Leap

Revolution in Packaging: Southeast Asia Steps Up Get ready for a wake-up call in the world of packaging, folks; the Southeast Asian market is taking a sharp turn toward sustainability and technological advancement, as highlighted by WEPSEA 2026's recent wrap-up in Shanghai. Far from a mere exhibition, this gathering served as the crucible for change, where old-school...

Papa John's Faces Investor Lawsuit: Class Action Looms

Papa John's in Hot Water Again? Look, just when you think the pizza game is all dough and cheesy goodness, along comes a legal scuffle to toss our assumptions. Bronstein, Gewirtz & Grossman, LLC has slapped a class action lawsuit against Papa John's International, Inc. (NASDAQ: PZZA), claiming the company and some of its higher-ups haven't been playing fair with the...